Inspire Medical Systems, Inc. (FRA:2DR)
106.60
-1.70 (-1.57%)
At close: Nov 28, 2025
Inspire Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 112.85 | 150.15 | 185.54 | 441.59 | 214.47 | 190.52 | Upgrade |
Short-Term Investments | 209.75 | 295.4 | 274.84 | 9.82 | - | 43.84 | Upgrade |
Cash & Short-Term Investments | 322.59 | 445.55 | 460.38 | 451.41 | 214.47 | 234.36 | Upgrade |
Cash Growth | -21.51% | -3.22% | 1.98% | 110.48% | -8.49% | 56.80% | Upgrade |
Receivables | 107.99 | 93.07 | 89.88 | 61.23 | 34.18 | 25.06 | Upgrade |
Inventory | 141.78 | 80.12 | 33.89 | 11.89 | 17.23 | 8.48 | Upgrade |
Prepaid Expenses | 14.13 | 12.07 | 9.6 | 5.51 | 2.66 | 1.97 | Upgrade |
Total Current Assets | 586.49 | 630.81 | 593.74 | 530.03 | 268.54 | 269.87 | Upgrade |
Property, Plant & Equipment | 115.58 | 95.24 | 62.65 | 24.13 | 16.41 | 11.12 | Upgrade |
Long-Term Investments | 104.75 | 81.6 | 19.54 | 10.5 | 9.94 | - | Upgrade |
Other Long-Term Assets | 0.9 | 0.74 | 0.88 | 0.22 | 0.2 | 0.2 | Upgrade |
Total Assets | 807.72 | 808.38 | 676.81 | 564.88 | 295.08 | 281.19 | Upgrade |
Accounts Payable | 59.24 | 38.69 | 38.84 | 26.85 | 11.67 | 7.21 | Upgrade |
Accrued Expenses | 47.76 | 45.52 | 37.59 | 32.08 | 19.67 | 13.36 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 9.19 | - | Upgrade |
Current Portion of Leases | 2.27 | 1.75 | - | 1.34 | 0.31 | - | Upgrade |
Current Income Taxes Payable | 1 | 1.61 | 0.58 | - | - | - | Upgrade |
Other Current Liabilities | 0.57 | 0.93 | 1.1 | 0.92 | 0.47 | 0.16 | Upgrade |
Total Current Liabilities | 110.84 | 88.5 | 78.11 | 61.19 | 41.31 | 20.73 | Upgrade |
Long-Term Debt | - | - | - | - | 15.8 | 24.75 | Upgrade |
Long-Term Leases | 30.3 | 30.04 | 24.85 | 7.54 | 8.8 | 5.89 | Upgrade |
Other Long-Term Liabilities | 0.11 | 0.15 | 1.35 | 0.15 | 0.13 | 0.09 | Upgrade |
Total Liabilities | 141.26 | 118.69 | 104.3 | 68.87 | 66.04 | 51.44 | Upgrade |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Additional Paid-In Capital | 948.37 | 981.04 | 917.11 | 820.34 | 508.47 | 467.04 | Upgrade |
Retained Earnings | -282.58 | -291.91 | -345.42 | -324.27 | -279.39 | -237.35 | Upgrade |
Comprehensive Income & Other | 0.64 | 0.54 | 0.8 | -0.09 | -0.06 | 0.03 | Upgrade |
Total Common Equity | 666.46 | 689.7 | 572.51 | 496.01 | 229.05 | 229.75 | Upgrade |
Shareholders' Equity | 666.46 | 689.7 | 572.51 | 496.01 | 229.05 | 229.75 | Upgrade |
Total Liabilities & Equity | 807.72 | 808.38 | 676.81 | 564.88 | 295.08 | 281.19 | Upgrade |
Total Debt | 32.58 | 31.79 | 24.85 | 8.87 | 34.1 | 30.63 | Upgrade |
Net Cash (Debt) | 290.02 | 413.75 | 435.53 | 442.54 | 180.37 | 203.73 | Upgrade |
Net Cash Growth | -24.80% | -5.00% | -1.58% | 145.35% | -11.46% | 64.15% | Upgrade |
Net Cash Per Share | 9.64 | 13.55 | 14.86 | 15.76 | 6.62 | 7.81 | Upgrade |
Filing Date Shares Outstanding | 29.06 | 29.67 | 29.59 | 29.05 | 27.53 | 27.13 | Upgrade |
Total Common Shares Outstanding | 29.05 | 29.74 | 29.56 | 29.01 | 27.42 | 27.07 | Upgrade |
Working Capital | 475.65 | 542.31 | 515.63 | 468.85 | 227.23 | 249.14 | Upgrade |
Book Value Per Share | 22.94 | 23.19 | 19.37 | 17.10 | 8.35 | 8.49 | Upgrade |
Tangible Book Value | 666.46 | 689.7 | 572.51 | 496.01 | 229.05 | 229.75 | Upgrade |
Tangible Book Value Per Share | 22.94 | 23.19 | 19.37 | 17.10 | 8.35 | 8.49 | Upgrade |
Machinery | 56.03 | 34.1 | 9.42 | 8.24 | 6.08 | 3.84 | Upgrade |
Construction In Progress | 26.06 | 24.98 | 33.21 | 11.86 | 5.18 | 3.13 | Upgrade |
Leasehold Improvements | 11.62 | 10.06 | 2.36 | 2.06 | 0.28 | 0.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.